Applied Pharmaceutical Innovation broke ground for a new 83,000 sq.foot Critical Medicines Production Centre In June. This new Production Centre will nearly double API’s footprint in Edmonton when complete in 2026. The plant will be able to produce more than 70 million doses of a vaccine, drug, or treatment yearly and can increase supply-chain security for common drugs.

API has received $80.5 million from the federal government and $17.6 million from the province to build the facility.The production facility is a collaboration between API and the University of Alberta’s Li Ka Shing Applied Virology Institute which partly funded by the $200-million Canadian Critical Drug Initiative.